rosu-asa® caps (20+100)mg/cap
iasis pharmaceuticals hellas ΒΙΟΜΗΧΑΝΙΑ ΚΑΙ ΕΜΠΟΡΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ - ΧΗΜΙΚΩΝ ΚΑΙ ΚΑΛΛΥΝΤΙΚΩΝ ΠΡΟΙΟΝΤΩΝ Α.Β.Ε.Ε., Δ.Τ. iasis pharma Λ. Φυλής 137,, 134 51 134 51, Καματερό 210.2311031 - rosuvastatin calcium; acetylsalicylic acid - caps (ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ) - (20+100)mg/cap - rosuvastatin calcium 20,8mg; acetylsalicylic acid 100mg - rosuvastatin and acetylsalisylic acid
rosu-asa® caps (10+100)mg/cap
iasis pharmaceuticals hellas ΒΙΟΜΗΧΑΝΙΑ ΚΑΙ ΕΜΠΟΡΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ - ΧΗΜΙΚΩΝ ΚΑΙ ΚΑΛΛΥΝΤΙΚΩΝ ΠΡΟΙΟΝΤΩΝ Α.Β.Ε.Ε., Δ.Τ. iasis pharma Λ. Φυλής 137,, 134 51 134 51, Καματερό 210.2311031 - rosuvastatin calcium; acetylsalicylic acid - caps (ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ) - (10+100)mg/cap - rosuvastatin calcium 10,4mg; acetylsalicylic acid 100mg - rosuvastatin and acetylsalisylic acid
rosu-asa® caps (5+100)mg/cap
iasis pharmaceuticals hellas ΒΙΟΜΗΧΑΝΙΑ ΚΑΙ ΕΜΠΟΡΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ - ΧΗΜΙΚΩΝ ΚΑΙ ΚΑΛΛΥΝΤΙΚΩΝ ΠΡΟΙΟΝΤΩΝ Α.Β.Ε.Ε., Δ.Τ. iasis pharma Λ. Φυλής 137,, 134 51 134 51, Καματερό 210.2311031 - rosuvastatin calcium; acetylsalicylic acid - caps (ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ) - (5+100)mg/cap - rosuvastatin calcium 5,2mg; acetylsalicylic acid 100mg - rosuvastatin and acetylsalisylic acid
pyralvex or.t.sol 1%+5% w/v
meda pharmaceuticals s.a., greece Αγίου Δημητρίου 63, 17456 Αλιμος 210.6775690 - salicylic acid; extractum rhei - or.t.sol (ΣΤΟΜΑΤΙΚΟ ΔΙΑΛΥΜΑ) - 1%+5% w/v - salicylic acid 10mg; extractum rhei 50mg - acetylsalicylic acid
aidol f.c.tab 500mg/tab
iasis pharmaceuticals hellas ΒΙΟΜΗΧΑΝΙΑ ΚΑΙ ΕΜΠΟΡΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ - ΧΗΜΙΚΩΝ ΚΑΙ ΚΑΛΛΥΝΤΙΚΩΝ ΠΡΟΙΟΝΤΩΝ Α.Β.Ε.Ε., Δ.Τ. iasis pharma Λ. Φυλής 137,, 134 51 134 51, Καματερό 210.2311031 - mefenamic acid - f.c.tab (ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ) - 500mg/tab - mefenamic acid 500mg - mefenamic acid
aidol oral.susp 50mg/5ml
iasis pharmaceuticals hellas ΒΙΟΜΗΧΑΝΙΑ ΚΑΙ ΕΜΠΟΡΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ - ΧΗΜΙΚΩΝ ΚΑΙ ΚΑΛΛΥΝΤΙΚΩΝ ΠΡΟΙΟΝΤΩΝ Α.Β.Ε.Ε., Δ.Τ. iasis pharma Λ. Φυλής 137,, 134 51 134 51, Καματερό 210.2311031 - mefenamic acid - oral.susp (ΠΟΣΙΜΟ ΕΝΑΙΩΡΗΜΑ) - 50mg/5ml - mefenamic acid 10mg - mefenamic acid
axibal f.c.tab 150mg/tab
iasis pharmaceuticals hellas ΒΙΟΜΗΧΑΝΙΑ ΚΑΙ ΕΜΠΟΡΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ - ΧΗΜΙΚΩΝ ΚΑΙ ΚΑΛΛΥΝΤΙΚΩΝ ΠΡΟΙΟΝΤΩΝ Α.Β.Ε.Ε., Δ.Τ. iasis pharma Λ. Φυλής 137,, 134 51 134 51, Καματερό 210.2311031 - ibandronic acid - f.c.tab (ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ) - 150mg/tab - ibandronic acid 150mg - ibandronic acid
clopidogrel taw pharma (previously clopidogrel mylan)
taw pharma (ireland) limited - υδροχλωρική κλοπιδογρέλη - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - Αντιθρομβωτικοί παράγοντες - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:, - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). , - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.
aidol 500mg tablets
iasis pharmaceuticals hellas sa (0000007836) 137 filis ave., kamatero, athens, 134 51 - mefenamic acid - tablets - 500mg - mefenamic acid (0000061687) 500mg - mefenamic acid
dynapen-3 soft.caps 1000(170+115)mg/cap
zwitter pharmaceuticals ΕΠΕ, greece Λεωφ. Πεντέλης 34-36,, 152 34 210 6821098 - fish oil (omega-3 polyunsaturated fatty acids) - soft.caps (ΚΑΨΑΚΙΟ, ΜaΛΑΚΟ) - 1000(170+115)mg/cap - fish oil (omega-3 polyunsaturated fatty acids) 1.000mg - omega-3-triglycerides incl. other esters and acids